title: High-dose therapy with autologous PBSC transplantation in the front-line treatment of Waldenstrom's macroglobulinemia.
authors.forename: T
authors.initials: T
authors.lastname: Caravita
authors.forename: A
authors.initials: A
authors.lastname: Siniscalchi
authors.forename: A
authors.initials: A
authors.lastname: Tendas
authors.forename: L
authors.initials: L
authors.lastname: Cupelli
authors.forename: T
authors.initials: T
authors.lastname: Dentamaro
authors.forename: G
authors.initials: G
authors.lastname: Natale
authors.forename: A
authors.initials: A
authors.lastname: Spagnoli
authors.forename: P
authors.initials: P
authors.lastname: de Fabritiis
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation; D000069283:Rituximab; D008258:Waldenstrom Macroglobulinemia / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000069283:Rituximab